<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Kimura K</submitter><funding>NEI NIH HHS</funding><funding>NIA NIH HHS</funding><funding>NIAID NIH HHS</funding><funding>NINDS NIH HHS</funding><pagination>718-731</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC12079183</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>641(8063)</volume><pubmed_abstract>Microglia are the resident immune cells in the brain and have pivotal roles in neurodevelopment and neuroinflammation&lt;sup>1,2&lt;/sup>. This study investigates the function of the immune-checkpoint molecule TIM-3 (encoded by HAVCR2) in microglia. TIM-3 was recently identified as a genetic risk factor for late-onset Alzheimer's disease&lt;sup>3&lt;/sup>, and it can induce T cell exhaustion&lt;sup>4&lt;/sup>. However, its specific function in brain microglia remains unclear. We demonstrate in mouse models that TGFβ signalling induces TIM-3 expression in microglia. In turn, TIM-3 interacts with SMAD2 and TGFBR2 through its carboxy-terminal tail, which enhances TGFβ signalling by promoting TGFBR-mediated SMAD2 phosphorylation, and this process maintains microglial homeostasis. Genetic deletion of Havcr2 in m</pubmed_abstract><journal>Nature</journal><pubmed_title>Immune checkpoint TIM-3 regulates microglia and Alzheimer's disease.</pubmed_title><pmcid>PMC12079183</pmcid><funding_grant_id>R01 AG054672</funding_grant_id><funding_grant_id>U19 AG069701</funding_grant_id><funding_grant_id>R21 AG076982</funding_grant_id><funding_grant_id>R01 EY027921</funding_grant_id><funding_grant_id>R01 NS088137</funding_grant_id><funding_grant_id>P30 AG066519</funding_grant_id><funding_grant_id>RF1 AG082704</funding_grant_id><funding_grant_id>R01 AG051812</funding_grant_id><funding_grant_id>R01 AG075509</funding_grant_id><funding_grant_id>P01 AI056299</funding_grant_id><funding_grant_id>P01 AI073748</funding_grant_id><funding_grant_id>R01 AG080992</funding_grant_id><funding_grant_id>R01 AI144166</funding_grant_id><pubmed_authors>Aastha A</pubmed_authors><pubmed_authors>Liu L</pubmed_authors><pubmed_authors>Suhail A</pubmed_authors><pubmed_authors>Suva ML</pubmed_authors><pubmed_authors>Zhang H</pubmed_authors><pubmed_authors>Kimura K</pubmed_authors><pubmed_authors>Kleemann KL</pubmed_authors><pubmed_authors>Kuchroo VK</pubmed_authors><pubmed_authors>Subramanian A</pubmed_authors><pubmed_authors>Cheng Y</pubmed_authors><pubmed_authors>Ding X</pubmed_authors><pubmed_authors>Adhikari N</pubmed_authors><pubmed_authors>Lambden C</pubmed_authors><pubmed_authors>Silveira S</pubmed_authors><pubmed_authors>Guzchenko I</pubmed_authors><pubmed_authors>Tang R</pubmed_authors><pubmed_authors>Weiner HL</pubmed_authors><pubmed_authors>Gupta N</pubmed_authors><pubmed_authors>Wu Y</pubmed_authors><pubmed_authors>Khalilnezhad A</pubmed_authors><pubmed_authors>Singh V</pubmed_authors><pubmed_authors>Dixon KO</pubmed_authors><pubmed_authors>Rozenblatt-Rosen O</pubmed_authors><pubmed_authors>He D</pubmed_authors><pubmed_authors>Blurton-Jones M</pubmed_authors><pubmed_authors>Chitta UK</pubmed_authors><pubmed_authors>Yin Z</pubmed_authors><pubmed_authors>Nomura M</pubmed_authors><pubmed_authors>Cruchaga C</pubmed_authors><pubmed_authors>Freeman GJ</pubmed_authors><pubmed_authors>Durao A</pubmed_authors><pubmed_authors>Eskandari-Sedighi G</pubmed_authors><pubmed_authors>Delorey T</pubmed_authors><pubmed_authors>Myers SA</pubmed_authors><pubmed_authors>Regev A</pubmed_authors><pubmed_authors>Zhang X</pubmed_authors><pubmed_authors>Selkoe DJ</pubmed_authors><pubmed_authors>Barry JL</pubmed_authors><pubmed_authors>Pertel T</pubmed_authors><pubmed_authors>Butovsky O</pubmed_authors></additional><is_claimable>false</is_claimable><name>Immune checkpoint TIM-3 regulates microglia and Alzheimer's disease.</name><description>Microglia are the resident immune cells in the brain and have pivotal roles in neurodevelopment and neuroinflammation&lt;sup>1,2&lt;/sup>. This study investigates the function of the immune-checkpoint molecule TIM-3 (encoded by HAVCR2) in microglia. TIM-3 was recently identified as a genetic risk factor for late-onset Alzheimer's disease&lt;sup>3&lt;/sup>, and it can induce T cell exhaustion&lt;sup>4&lt;/sup>. However, its specific function in brain microglia remains unclear. We demonstrate in mouse models that TGFβ signalling induces TIM-3 expression in microglia. In turn, TIM-3 interacts with SMAD2 and TGFBR2 through its carboxy-terminal tail, which enhances TGFβ signalling by promoting TGFBR-mediated SMAD2 phosphorylation, and this process maintains microglial homeostasis. Genetic deletion of Havcr2 in m</description><dates><release>2025-01-01T00:00:00Z</release><publication>2025 May</publication><modification>2026-06-05T09:28:28.148Z</modification><creation>2026-05-15T03:12:44.822Z</creation></dates><accession>S-EPMC12079183</accession><cross_references><pubmed>40205047</pubmed><doi>10.1038/s41586-025-08852-z</doi></cross_references></HashMap>